Margrét Agnarsdóttir

Author

Also Known As

M Agnarsdottir, M. Agnarsdottir, Margret Agnarsdottir, Margret Agnarsdóttir, Margret Agnarsdóttir,, Margrét Agnarsdóttir

Publications

689

Citations

H-Index

Concepts

All Affiliations

Uppsala University Hospital Uppsala University Science for Life Laboratory University College Dublin KTH Royal Institute of Technology

About

Margrét Agnarsdóttir is an author at Uppsala University Hospital specializing in medicine, tumor biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	218
2	Cell Biology	3	3	106
3	Health Sciences	2	2	70
4	Public Health	1	1	12
5	Gastroenterology	1	1	27

Margrét Agnarsdóttir

Publications

661

Citations

H-Index

Page 1

	Year	Citations
Collagenous and Lymphocytic Colitis in Iceland Margrét Agnarsdóttir, Ólafur Gunnlaugsson, Kjartan B. Örvar, Digestive Diseases and Sciences	2002	141
An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers Artur Mezheyeuski, Max Backman, Johanna Sofia Margareta Mattsson, EBioMedicine	2023	72
WNT5A-mediated -catenin-independent signalling is a novel regulator of cancer cell metabolism Victoria Sherwood, Shivendra K. Chaurasiya, Elin Ekström, Carcinogenesis Cancer Cell MetabolismMetabolic RemodelingWnt5a SignallingCancer BiologyTumor Biology	2013	48
Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients Angelica Loskog, Aglaia Maleka, Sara M. Mangsbo, British Journal of Cancer	2016	46
SATB2 is expressed in Merkel cell carcinoma Mari Fukuhara, Margrét Agnarsdóttir, Per‐Henrik Edqvist, Archives of Dermatological Research MedicinePathologyCancer GeneticsMerkel Cell CarcinomaCancer Biology	2016	46
SOX10 expression in superficial spreading and nodular malignant melanomas Margrét Agnarsdóttir, Linda Sooman, Åsa Bolander, Melanoma Research Tumoral PathologyMalignant DiseaseMedicineMelanomaPathology	2010	36
Fecal eosinophil cationic protein as a marker of active disease and treatment outcome in collagenous colitis: A pilot study Michael Wagner, Christer Peterson, Ingrid Stolt, Scandinavian Journal of Gastroenterology	2011	36
The protein expression of TRP-1 and galectin-1 in cutaneous malignant melanomas. Åsa Bolander, Margrét Agnarsdóttir, Sara Strömberg, PubMed	2009	35
Clinical features of microscopic colitis in a nation-wide follow-up study in Iceland Ólafur Sveinsson, Kjartan B. Örvar, Sigurbjörn Birgisson, Scandinavian Journal of Gastroenterology	2008	33
Budesonide treatment of patients with collagenous colitis restores normal eosinophil and T-cell activity in the colon Michael Wagner, Maria Lampinen, Per Sangfelt, Inflammatory Bowel Diseases	2009	32

Page 1